Interleukin-1 blockers for the treatment of recurrent pericarditis: pathophysiology, patient reported outcomes and perspectives.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of cardiovascular pharmacology"
DOI: 10.1097/fjc.0000000000001435
Abstract: ABSTRACT Recurrent pericarditis (RP) is the most troublesome complication of acute pericarditis reflecting an unresolving inflammation of the pericardial sac around the heart and associated with significant morbidity. Recent studies have shown interleukin-1 (IL-1) signaling… read more here.
Keywords: pathophysiology; pericarditis; recurrent pericarditis; blockers treatment ... See more keywords
Paradoxical gastrointestinal effects of interleukin-17 blockers
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218719
Abstract: We read with great interest the review written by Fauny et al 1 which describes the relevance of interleukin-23/T-helper 17 (IL-23/Th17) pathway in inflammatory bowel disease (IBD). However, drugs targeting IL-17 have shown the opposite… read more here.
Keywords: gastrointestinal effects; paradoxical gastrointestinal; effects interleukin; interleukin blockers ... See more keywords